Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a)

Proceedings of the National Academy of Sciences of the United States of America
Isil GuneyJohn M Sedivy

Abstract

Increased mitogenic signaling by positive effectors such as Ras or Myc can trigger senescence in normal cells, a response believed to function as a tumor-suppressive mechanism. We report here the existence of a checkpoint that monitors hypoproliferative signaling imbalances. Normal human fibroblasts with one copy of the c-myc gene inactivated by targeted homologous recombination switched with an increased frequency to a telomere-independent senescent state mediated by the cyclin-dependent kinase inhibitor p16(INK4a). p16(INK4a) expression was regulated by the Polycomb group repressor Bmi-1, which we show is a direct transcriptional target of c-Myc. The Myc-Bmi circuit provides a mechanism for the conversion of environmental inputs that converge on c-Myc into discrete cell-fate decisions coupled to cell-cycle recruitment. A mechanism for limiting the proliferation of damaged or otherwise physiologically compromised cells would be expected to have important consequences on the generation of replicatively senescent cells during organismal aging.

Associated Clinical Trials

References

Jun 23, 1999·Oncogene·C E NesbitE V Prochownik
May 18, 2001·Nature·G I Evan, K H Vousden
Feb 9, 2002·Nature Cell Biology·Alison C Lloyd
Mar 12, 2002·Advances in Cancer Research·Sara K OsterLinda Z Penn
Mar 15, 2002·Current Opinion in Genetics & Development·Jeffrey A Simon, John W Tamkun
Dec 17, 2002·Molecular and Cellular Biology·Koji ItahanaGoberdhan P Dimri
Jan 17, 2003·The Journal of Biological Chemistry·Brenda C O'ConnellJohn M Sedivy
Mar 22, 2003·RNA·Sheila A StewartCarl D Novina
Apr 16, 2003·Genes & Development·Paula C FernandezBruno Amati
Jul 5, 2003·Genes & Development·Carla GrandoriRaymond J Monnat
Aug 13, 2003·The EMBO Journal·Christian M BeauséjourJudith Campisi
Sep 6, 2003·Current Biology : CB·Hiroyuki TakaiTitia de Lange
Oct 31, 2003·Cancer Cell·P Mathijs Voorhoeve, Reuven Agami
Nov 11, 2003·Nature·Fabrizio d'Adda di FagagnaStephen P Jackson
Nov 3, 2004·The Journal of Clinical Investigation·Janakiraman KrishnamurthyNorman E Sharpless

❮ Previous
Next ❯

Citations

Jul 31, 2013·Cellular and Molecular Life Sciences : CMLS·Leonidas BenetatosEleftheria Hatzimichael
Dec 2, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Caihua ZhuMeiyu Geng
May 20, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chia-Hsin ChanHui-Kuan Lin
Feb 12, 2008·Journal of Cancer Research and Clinical Oncology·Katerina VrzalikovaZdenek Kolar
Feb 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hui WangRui Ling
Aug 22, 2009·Cell Death and Differentiation·N R ChristoffersenA H Lund
Jun 24, 2008·Nature·Arthur L ShafferLouis M Staudt
Dec 23, 2009·Nature Cell Biology·Jan van Riggelen, Dean W Felsher
Jul 17, 2007·Nature Medicine·Christine DierksMarkus Warmuth
Aug 22, 2006·Nature Reviews. Molecular Cell Biology·Jesús Gil, Gordon Peters
Dec 18, 2007·Oncogene·J P ZwernerW A May
Dec 8, 2009·Proceedings of the National Academy of Sciences of the United States of America·Per HydbringLars-Gunnar Larsson
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Karen M OngCarson C Chow
Jul 22, 2010·The Journal of Biological Chemistry·Tulsiram PrathapamG Steven Martin
Oct 25, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tatyana A KlimovaNavdeep S Chandel
Aug 23, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ruimin HuangRonald G Blasberg
Mar 26, 2009·Current Opinion in Hematology·Michael S GoligorskySusann Patschan
Apr 20, 2013·Genes & Development·Xavier Deschênes-SimardGerardo Ferbeyre
Dec 15, 2010·Pigment Cell & Melanoma Research·Sandy GiulianoCorine Bertolotto
May 1, 2013·The Journal of Veterinary Medical Science·Hideyoshi KawasakiKoichi Sato
Sep 17, 2013·PloS One·Victoria FloreaClaudia O Rodrigues
Nov 30, 2011·Epigenomics·Koji Itahana, Goberdhan P Dimri
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yingjie ShaoHonglei Pei
Aug 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Chi-Hwa WuDean W Felsher
Nov 13, 2012·Annual Review of Physiology·Judith Campisi
Aug 23, 2012·American Journal of Clinical Pathology·Tonia CenciLuigi Maria Larocca
Oct 1, 2011·Hormone Molecular Biology and Clinical Investigation·Viola LorenzAria Baniahmad
Mar 25, 2011·Cell Cycle·Anagh A SahasrabuddheGoberdhan P Dimri
May 9, 2014·Frontiers in Endocrinology·Sylvie RemaudBarbara A Demeneix

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.